My concern is this: the federal government pays 30% of the cost of the common drug review and the federal people here seem to be saying it's good for them, but if it's such expert advice, how come they're funding things that get negative recommendations?
Mr. Chairman, I understand the provinces are doing the same thing. In some cases, they are not listing the drugs that got a positive recommendation from the CDR and they are listing the drugs that got a negative recommendation. If this is all such highfalutin, perfect expert advice, how come nobody is obeying the recommendations? Everybody is doing it, both recommending and not recommending, totally opposite to what the CDR is saying.
What are we paying for here?